Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IREN vs MRNA✓SelectedUSD · MRNAIREN vs MRNA performance historyLatest closeAs of-17.97%11/20
Stock and ETF performance explorer

IREN vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-47.8%
MRNA return
-27.3%
Excess return
-20.5%
Maximum drawdown
-95.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-18.0%-2.2%-15.8%-17.6%
7D-34.9%-12.7%-22.2%-33.5%
30D-57.5%-20.7%-36.9%-56.0%
3M-72.3%+46.3%-118.5%-74.0%
6M-77.6%+305.2%-382.8%-85.7%
YTD-68.7%+561.2%-629.9%-83.3%
1Y-72.8%+772.1%-844.9%-86.9%
3Y+302.0%+147.0%+155.1%+172.0%
All-47.8%-27.3%-20.5%-52.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling